Literature DB >> 2203350

Affinity purification of HIV-1 and HIV-2 proteases from recombinant E. coli strains using pepstatin-agarose.

J Rittenhouse1, M C Turon, R J Helfrich, K S Albrecht, D Weigl, R L Simmer, F Mordini, J Erickson, W E Kohlbrenner.   

Abstract

A procedure is described which employs pepstatin-agarose for the affinity purification of either HIV-1 or HIV-2 protease from two similar recombinant E. coli constructs that were developed for the expression of these enzymes. HIV-2 protease was routinely expressed at much higher levels than the HIV-1 enzyme and pepstatin-agarose was the only chromatography step required to isolate pure HIV-2 protease from crude bacterial lysates. A Mono S ionic exchange step following pepstatin-agarose chromatography was sufficient to bring the HIV-1 protease to homogeneity. Purification of either enzyme can be completed in several days yielding homogeneous preparations suitable for crystallization and other physical characterization.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2203350     DOI: 10.1016/0006-291x(90)91356-w

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Characterization of a novel RNA-binding region of eIF4GI critical for ribosomal scanning.

Authors:  Déborah Prévôt; Didier Décimo; Cécile H Herbreteau; Florence Roux; Jérôme Garin; Jean-Luc Darlix; Théophile Ohlmann
Journal:  EMBO J       Date:  2003-04-15       Impact factor: 11.598

2.  Phosphorylation and proteolytic cleavage of gag proteins in budded simian immunodeficiency virus.

Authors:  Sarah M Rue; Jason W Roos; Patrick M Tarwater; Janice E Clements; Sheila A Barber
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

3.  Antiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 protease.

Authors:  D J Kempf; K C Marsh; D A Paul; M F Knigge; D W Norbeck; W E Kohlbrenner; L Codacovi; S Vasavanonda; P Bryant; X C Wang
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

4.  Revealing the dimer dissociation and existence of a folded monomer of the mature HIV-2 protease.

Authors:  John M Louis; Rieko Ishima; Annie Aniana; Jane M Sayer
Journal:  Protein Sci       Date:  2009-12       Impact factor: 6.725

5.  HIV protease cleaves poly(A)-binding protein.

Authors:  Enrique Alvarez; Alfredo Castelló; Luis Menéndez-Arias; Luis Carrasco
Journal:  Biochem J       Date:  2006-06-01       Impact factor: 3.857

6.  In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 protease.

Authors:  M J Otto; S Garber; D L Winslow; C D Reid; P Aldrich; P K Jadhav; C E Patterson; C N Hodge; Y S Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

7.  High-level expression and purification of mature HIV-1 protease in Escherichia coli under control of the araBAD promoter.

Authors:  A Taylor; D P Brown; S Kadam; M Maus; W E Kohlbrenner; D Weigl; M C Turon; L Katz
Journal:  Appl Microbiol Biotechnol       Date:  1992-05       Impact factor: 4.813

8.  The eukaryotic translation initiation factor 4GI is cleaved by different retroviral proteases.

Authors:  Enrique Alvarez; Luis Menéndez-Arias; Luis Carrasco
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

9.  HIV-2 Protease resistance defined in yeast cells.

Authors:  Najoua Ben M'Barek; Gilles Audoly; Didier Raoult; Pablo Gluschankof
Journal:  Retrovirology       Date:  2006-09-06       Impact factor: 4.602

10.  GCN2 has inhibitory effect on human immunodeficiency virus-1 protein synthesis and is cleaved upon viral infection.

Authors:  Javier del Pino; José Luis Jiménez; Iván Ventoso; Alfredo Castelló; Ma Ángeles Muñoz-Fernández; César de Haro; Juan José Berlanga
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.